Barry M. Lester

The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants.

The Maternal Lifestyle Study (MLS): effects of prenatal cocaine and/or opiate exposure on auditory brain response at one month.

Smoking during pregnancy and newborn neurobehavior.

Comparison of motor self-regulatory and stress behaviors of preterm infants across body positions.

History and description of the Neonatal Intensive Care Unit Network Neurobehavioral Scale.

The Neonatal Intensive Care Unit Network Neurobehavioral Scale procedures.

Summary statistics of neonatal intensive care unit network neurobehavioral scale scores from the maternal lifestyle study: a quasinormative sample.

Normative neurobehavioral performance of healthy infants on the Neonatal Intensive Care Unit Network Neurobehavioral Scale.

Clinical use of the Neonatal Intensive Care Unit Network Neurobehavioral Scale.

Substance use during pregnancy: time for policy to catch up with research.

The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age.

Predictors of motor development in children prenatally exposed to cocaine.

Interactions between maternal characteristics and neonatal behavior in the prediction of parenting stress and perception of infant temperament.

Assessment of infant cry: acoustic cry analysis and parental perception.

Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.

Low birth weight and preterm births: etiologic fraction attributable to prenatal drug exposure.

The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth.

Prenatal cocaine use and maternal depression: effects on infant neurobehavior.

Impact of maternal substance use during pregnancy on childhood outcome.

Violence and delinquency, early onset drug use, and psychopathology in drug-exposed youth at 11 years.

Prenatal cocaine exposure: cardiorespiratory function and resilience.

Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, environment, and lifestyle study (IDEAL).

Vagal tone as a resilience factor in children with prenatal cocaine exposure.

Prenatal methamphetamine use and neonatal neurobehavioral outcome.

Mother-infant consultation during drug treatment: research and innovative clinical practice.

Growth trajectories of preterm infants: birth to 12 years.

Importance of stability of early living arrangements on behavior outcomes of children with and without prenatal drug exposure.

The effect of parenting stress on child behavior problems in high-risk children with prenatal drug exposure.

Maternal depression and neurobehavior in newborns prenatally exposed to methamphetamine.

Treatment of substance abuse during pregnancy.

Novel biomarkers of prenatal methamphetamine exposure in human meconium.

Third pathophysiology of prenatal cocaine exposure.

Functional MRI and response inhibition in children exposed to cocaine in utero. Preliminary findings.

Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study.

Fetal effects of psychoactive drugs.

Longitudinal study of maternal report of sleep problems in children with prenatal exposure to cocaine and other drugs.

Infant neurobehavioral dysregulation: behavior problems in children with prenatal substance exposure.

Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study.

New meconium biomarkers of prenatal methamphetamine exposure increase identification of affected neonates.

Variations of NICU sound by location and time of day.

Parenting intervention for externalizing behavior problems in children born premature: an initial examination.

Prenatal cocaine exposure related to cortisol stress reactivity in 11-year-old children.

Children of addicted women.

Small for gestational age and higher birth weight predict childhood obesity in preterm infants.

Parent-Child Interaction Therapy for Children Born Premature: A Case Study and Illustration of Vagal Tone as a Physiological Measure of Treatment Outcome.

Sleep problems in children with prenatal substance exposure: the Maternal Lifestyle study.

Prenatal cocaine exposure and BMI and blood pressure at 9 years of age.

Building for the future of Rhode Island's newborns.

Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study.

Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand.

A preliminary study of cortisol reactivity and behavior problems in young children born premature.

Services used by perinatal substance-users with child welfare involvement: a descriptive study.

Vulnerable infants program of Rhode Island: promoting permanency for substance-exposed infants.

Prenatal cocaine exposure and childhood obesity at nine years.

Serial pediatric symptom checklist screening in children with prenatal drug exposure.

Infant neurobehavioral development.

Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine.

Long-term impact of maternal substance use during pregnancy and extrauterine environmental adversity: stress hormone levels of preadolescent children.

Behavioral epigenetics.

Impact of prenatal exposure to cocaine and tobacco on diffusion tensor imaging and sensation seeking in adolescents.

The combined effects of prenatal drug exposure and early adversity on neurobehavioral disinhibition in childhood and adolescence.

The effects of prenatal methamphetamine exposure on childhood growth patterns from birth to 3 years of age.

Prenatal cocaine exposure and small-for-gestational-age status: effects on growth at 6 years of age.

After family treatment drug court: maternal, infant, and permanency outcomes.

Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment.

Major depressive disorder during pregnancy and emotional attachment to the fetus.

Reconceptualizing in a dual-system model the effects of prenatal cocaine exposure on adolescent development: a short review.

Placenta-imprinted gene expression association of infant neurobehavior.

Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes.

Prenatal methamphetamine exposure and inhibitory control among young school-age children.

Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age.

Placental 11-beta hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome.

A care coordination program for substance-exposed newborns.

Perceived child behavior problems, parenting stress, and maternal depressive symptoms among prenatal methamphetamine users.

Maternal depression and prenatal exposure to methamphetamine: neurodevelopmental findings from the infant development, environment, and lifestyle (ideal) study.

Predictors of inadequate prenatal care in methamphetamine-using mothers in New Zealand and the United States.

Neurobehavioral disinhibition predicts initiation of substance use in children with prenatal cocaine exposure.

An initial investigation of baseline respiratory sinus arrhythmia as a moderator of treatment outcome for young children born premature with externalizing behavior problems.

Evidence-based intervention for young children born premature: preliminary evidence for associated changes in physiological regulation.

Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand.

Atypical cry acoustics in 6-month-old infants at risk for autism spectrum disorder.

Subcortical and cortical structural central nervous system changes and attention processing deficits in preschool-aged children with prenatal methamphetamine and tobacco exposure.

Examining the relationships between prenatal methamphetamine exposure, early adversity, and child neurobehavioral disinhibition.

Neonatal neurobehavior effects following buprenorphine versus methadone exposure.

Protective factors can mitigate behavior problems after prenatal cocaine and other drug exposures.

Regional brain morphometry and impulsivity in adolescents following prenatal exposure to cocaine and tobacco.

Cortisol reactivity in two-year-old children prenatally exposed to methamphetamine.

Prenatal substance exposure: neurobiologic organization at 1 month.

Epigenetic basis for the development of depression in children.

Placental miRNA expression profiles are associated with measures of infant neurobehavioral outcomes.

A flexible analysis tool for the quantitative acoustic assessment of infant cry.

Placental HTR2A methylation is associated with infant neurobehavioral outcomes.

Grandchild of the NBAS: the NICU network neurobehavioral scale (NNNS): a review of the research using the NNNS.

Cross-national Comparison of Prenatal Methamphetamine Exposure on Infant and Early Child Physical Growth: A Natural Experiment.

Patterning in placental 11-B hydroxysteroid dehydrogenase methylation according to prenatal socioeconomic adversity.

Emotional expression and heart rate in high-risk infants during the face-to-face/still-face.

The roles of DNA methylation of NR3C1 and 11β-HSD2 and exposure to maternal mood disorder in utero on newborn neurobehavior.

Risk-taking behavior among adolescents with prenatal drug exposure and extrauterine environmental adversity.

Global and gene-specific DNA methylation across multiple tissues in early infancy: implications for children's health research.

Sex-specific associations between placental leptin promoter DNA methylation and infant neurobehavior.

Risk of neurobehavioral disinhibition in prenatal methamphetamine-exposed young children with positive hair toxicology results.

Prenatal methamphetamine exposure and neurodevelopmental outcomes in children from 1 to 3 years.

Reactivity and regulation of motor responses in cocaine-exposed infants.

Effects of prenatal methamphetamine exposure on behavioral and cognitive findings at 7.5 years of age.

Are epigenetic changes in the intrauterine environment related to newborn neurobehavior?

The contributions of early adverse experiences and trajectories of respiratory sinus arrhythmia on the development of neurobehavioral disinhibition among children with prenatal substance exposure.

Structural Brain Imaging in Children and Adolescents following Prenatal Cocaine Exposure: Preliminary Longitudinal Findings.

Epigenetic Variation in the Mu-Opioid Receptor Gene in Infants with Neonatal Abstinence Syndrome.

Physiological Correlates of Neurobehavioral Disinhibition that Relate to Drug Use and Risky Sexual Behavior in Adolescents with Prenatal Substance Exposure.

Placental FKBP5 Genetic and Epigenetic Variation Is Associated with Infant Neurobehavioral Outcomes in the RICHS Cohort.